Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/SPYRE-THERAPEUTICS-INC-27114072/noticia/Immedica-Pharma-adquiri-los-derechos-mundiales-sobre-la-pegzilarginasa-de-Aeglea-BioTherapeutics-44445309/?utm_source=whatsapp&utm_medium=social&utm_campaign=share